Fat Science

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright explore one of the most contentious topics in the world of health and fitness: the definition and measurement of fat.  BMI (Body Mass Index) has long been the standard, but recent studies have called its efficacy into question. Dr. Cooper reveals why BMI can be a flawed indicator of health, exploring alternate measurements like waist circumference and body composition while discussing their limitations and potential misuses.  This episode highlights the real issue: identifying and treating metabolic dysfunction and achieving true health beyond just numbers on a scale or tape measure. Key Takeaways:  BMI: A Flawed Metric? Dr. Cooper reveals the limitations of BMI. She shares intriguing insights into how factors like muscle mass and gender-specific body composition can skew BMI readings and recounts fascinating stories from her career, including a case where an Olympic athlete was classified as obese purely based on BMI. The Lancet's Insight. The team discusses a recent paper by the esteemed Lancet Commission, which argues for de-emphasizing BMI in favor of other health indicators. They dive into the importance of looking at the complete clinical picture, including blood sugar swings, energy levels, and more. Anecdotes and Real-life Experiences. Andrea Taylor shares her journey of struggling with various diets until discovering metabolic dysfunction as the root problem.  Insurance and Medical Ethics. Discover the ethical dilemmas of using BMI for decisions on insurance coverage and medical treatments. Mark brings attention to startling cases where statistically healthy individuals were denied life insurance based on high BMI. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org. Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright explore five New Year’s resolutions you can make (and not break) for a healthier 2025. The conversation shifts away from unattainable goals and toward practical steps for enhancing overall well-being in the new year. Key Takeaways: Address Metabolic SyndromeIf you suspect you have metabolic syndrome, 2025 is the year to take action. Dr. Cooper explains how to identify and address it with testing and medical guidance. Health Over Beach BodyShift the focus from attaining a "beach body" to improving your overall health. Andrea discusses the importance of self-acceptance and the harm of societal pressures. Don't DietCommit to not dieting. Dr. Cooper emphasizes the metabolic dangers of calorie restriction and the benefits of balanced nutrition. Get Enough SleepQuality sleep is crucial for metabolic health. Learn why 7-9 hours of sleep and timing your sleep cycles matter. Be Kind to YourselfEmbrace self-love and physiologic intuition. Andrea shares how this has transformed her relationship with food and body image. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org. Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright field questions from listeners. Throughout the show, our hosts highlight the importance of compassionate, science-based medical care and underscore the significance of finding healthcare providers who address metabolic issues as medical, not lifestyle, concerns. Among the topics addressed:  Statins & Weight Gain: We discuss concerns about the relationship between statin use and weight gain, addressing fears of indefinite use and potential side effects related to diabetes risk. “Normal” Lab Results Despite Symptoms: Kate questions why lab results might appear normal while still experiencing symptoms of metabolic dysfunction.  Gut Health Impact on Metabolism: We cover the link between gut health and metabolic dysfunction, emphasizing the importance of gut motility and microbiome balance. Pregnancy and Metabolic Changes: Dr. Cooper discusses how pregnancy can impact metabolic function, with some women experiencing improvements while others may face challenges like gestational diabetes. Genetics: Dr. Emily Cooper delves into how metabolic disorders can be transferred to offspring, noting that these issues can be triggered and amplified with each pregnancy. Barbara inquires about the safety of GLP1 medications given a history of papillary thyroid cancer. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org. Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright take a comprehensive look at the current FDA-approved medications designed to treat metabolic dysfunction and what may be approved next.  Dr. Cooper discusses the range of factors that determine whether these essential drugs are available for those who need them. Government approval, drug company strategies and insurance company policies all play a role.  Key Takeaways: Pharmaceutical Approval Process: Pharmaceutical companies typically seek FDA approval for one drug indication at a time due to the high costs and extensive trial requirements. Approval for obesity drugs is more stringent than for diabetes, involving costly and rigorous trials. Rebranding Drugs for Accessibility: Drugs like Liraglutide (originally Victoza for diabetes) are rebranded as Saxenda for obesity to bypass insurance coverage issues. However, rebranding can create coverage gaps for weight-loss purposes, leaving some patients without access. Insurance Coverage Challenges: Insurance companies often limit coverage for these medications unless a patient has a diagnosed condition like type 2 diabetes. Preventative benefits of metabolic medications are frequently overlooked by insurers, limiting broader access. Risks with Compounded Medications: Compounding pharmacies are creating untested versions of GLP-1 drugs to address affordability and shortages, raising safety concerns. Future Developments in Metabolic Meds: New potential drugs, such as a dual hormone agonist and high-dose semaglutide as a daily pill, show promise in improving metabolic health and accessibility. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org. Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/

Discover the vital role of metabolic lab tests in diagnosing issues like pre-diabetes and high cholesterol. Learn how blood markers can paint a comprehensive picture of your health. Personal stories highlight real journeys in metabolic management, emphasizing consistency and dedication to treatment. The impact of diet on lab results is explored, along with the importance of ongoing monitoring. Finally, hear insights about the collaborative relationship between patients and healthcare providers, promoting open communication and a shame-free understanding of health.

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright tackle the challenges of maintaining metabolic health during the holiday season. Dr. Cooper emphasizes the importance of keeping a regular routine to manage stress and avoid metabolic disruptions. The team shares practical advice for navigating family gatherings and enjoying the holidays without compromising your health. Key Takeaways: Society's excessive focus on weight and appearance can be harmful; value shouldn't be based on physical changes. GLP1 medications need to be introduced gradually; skipping meals while on them can disrupt metabolism. Avoid contentious family discussions about weight, diet, and metabolism to prevent stress. Tryptophan in turkey is not the cause of post-meal drowsiness; overeating likely is. Stick to regular sleep and eating patterns to manage stress and maintain metabolic health. Extreme exercise during holidays can raise cortisol levels; maintaining a consistent routine is better. Family traditions and memories are important; a balanced approach to holiday eating can improve your overall experience. Personal Stories & Practical Advice: Andrea discusses her family's tradition of holiday baking and her evolving relationship with food. Mark shares memories of Scandinavian holiday foods and the comfort he finds in holiday eating traditions. Dr. Cooper advises on balancing food intake and avoiding overemphasis on weight loss during holidays. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org. Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/ 

In this episode of Fat Science, hosts Dr. Emily Cooper, Andrea Taylor, and Mark Wright explore the compelling and urgent topic of COVID-19's impact on metabolic health. COVID-19 has introduced a serious new layer of complexity because it can exacerbate existing conditions like diabetes, obesity, cardiovascular and thyroid disease.  The latest data reveal a shocking statistic—the risk of developing diabetes can increase by up to 40 percent after a COVID infection.  So what should we know about these risks, and how can scientific insight help us navigate this new terrain? Key Discussion Points: Early Data and Predictions: Insights from Dr. Cooper's clinic, supported by the Diabesity Institute, which identified early links between COVID-19 and metabolic disease risk. Real-World Impacts: The clinic’s database comprising around 2,500 patients with more than 10 years of data, which showcases the regression of metabolic health progress post-pandemic. Public Health: The importance of vaccinations, continuous COVID monitoring, and preventive practices to mitigate these risks. Metabolic Meds: The role of medications like Metformin and Ozempic in managing complications from pre-diabetes and diabetes, particularly during COVID. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope.  Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

In this episode of Fat Science, hosts Dr. Emily Cooper, Andrea Taylor and Mark Wright explore eating disorders, disordered eating and their profound impact on metabolic health. Eating disorders and disordered eating are much more common than people realize, affect a significant portion of the population and contribute to serious metabolic issues. So what are eating disorders and disordered eating? How do they differ, and what are the health implications? Listeners will gain a deep understanding of the spectrum of eating behaviors, from normal eating to clinically dangerous eating disorders.   Disordered Eating: Behaviors such as repeated dieting, calorie restriction, carb restriction, intermittent fasting, and keto diets, often accompanied by an excessive focus on body image, body shape and body size. This is prevalent in the majority of the population. Eating Disorders: Clinically dangerous conditions like anorexia nervosa, bulimia nervosa, and ARFID, which are life-threatening and require aggressive medical intervention. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope.  Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

In this episode of Fat Science, hosts Dr. Emily Cooper, Andrea Taylor and Mark Wright tackle the topic of insulin resistance and its impact on metabolic health.  It’s estimated one in three Americans has the condition, which often leads to prediabetes and even full-blown diabetes.  So what is insulin resistance? How can we tell if we have it? And what can we do to reverse it?  Listeners will gain a comprehensive understanding of how lifestyle, nutrition and medication can influence metabolic function and insulin sensitivity. Key Takeaways: Insulin’s Role: Insulin is an anabolic hormone essential for transporting energy throughout the body and for muscle mass retention, with high levels leading to increased muscle and body fat. Insulin Resistance: Often a precursor to metabolic syndrome, it can lead to prediabetes, diabetes, and hypertension by altering liver fat production and impacting heart health. Environmental Factors: Awareness of endocrine disruptors and their influence on metabolic health. Treatment: Exploring medications like Metformin and emerging treatments such as GLP1 GIP dual agonists for reducing insulin resistance. Hormonal Influence: Highlighting the roles of adiponectin and leptin in metabolic health and their improvement through lifestyle changes and medications. Resources: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope.  Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a show idea, feedback, or just want to connect, email info@diabesityinstitute.org.

In this episode of Fat Science, hosts Mark Wright, Andrea Taylor, and Dr. Emily Cooper delve into the intricate relationship between mood and metabolism. They explore how our body chemistry influences our emotional states and the significant impact that factors like sleep and blood sugar levels have on mood regulation. Key topics discussed include: Mood and Metabolism: Dr. Cooper explains how fluctuations in blood sugar can lead to emotional disturbances, including feelings of anxiety and low motivation. The hosts share personal anecdotes about how hunger and lack of sleep can affect their moods. The Role of Sleep: The conversation highlights the importance of sleep for overall health, emphasizing its critical role in metabolic function and mood stability. Dr. Cooper notes that poor sleep can exacerbate metabolic issues, leading to a cycle of mood disorders. Impact of Mood Disorder Medications: The episode addresses various medications used to treat mood disorders, discussing their effects on metabolism. Listeners learn about the potential side effects, including weight gain and insulin resistance, associated with common antidepressants and ADHD medications. Understanding Appetite Suppressants: The hosts discuss misconceptions around appetite suppressants and stimulants, revealing that while they may reduce hunger, they do not necessarily boost metabolic rates. This segment cautions against relying on such medications for weight management. Resources from the episode: Connect with Dr. Emily Cooper on LinkedIn. Connect with Mark Wright on LinkedIn. Connect with Andrea Taylor on Instagram. Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope. Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice. If you have a show idea, feedback, or just want to connect, email info@diabesityinstitute.org.